TERN Stock Analysis: Buy, Sell, or Hold?
TERN - Terns Pharmaceuticals, Inc. Common Stock
$34.60
0.40 (1.17%)
β²
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Mar 19, 2026
Get Alerted When TERN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
β BUY SIGNAL: TERN shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
β BUY SIGNAL: TERN shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: TERN is currently trading at $34.60, which is considered oversold relative to its 30-day fair value range of $34.85 to $40.32.
Technical Outlook: Technically, TERN is in a strong uptrend. Immediate support is located at $33.53, while resistance sits at $38.24.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $58.12 (+70.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TERN is in a strong uptrend. Immediate support is located at $33.53, while resistance sits at $38.24.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $58.12 (+70.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$34.85 -
$40.32
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 70.0% below Wall St target ($58.12)
Fair Price Analysis
30-Day Fair Range
$34.85 -
$40.32
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$33.53
Resistance Level
$38.25
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-28.24
Wall Street Target
$58.13
(+70.0%)
Last updated: January 31, 2026 2:33 PM ET
Data refreshes hourly during market hours. Next update: 3:33 PM
Data refreshes hourly during market hours. Next update: 3:33 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TERN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Emil Kuriakose
SELL
944 shares
2025-10-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$214 | 60 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
RCKT
Rocket Pharmaceuticals I⦠|
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
Advanced TERN Option Strategies
Professional options setups generated by AI based on today's TERN price and gamma walls.